title: New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
authors.affiliation: Unité de Recherche en Neuroscience, Centre de Recherche du CHUQ, Institut Universitaire de Gériatrie de Montreal, Montreal, Quebec, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Hadj Tahar
authors.forename: R
authors.initials: R
authors.lastname: Grondin
authors.forename: L
authors.initials: L
authors.lastname: Grégoire
authors.forename: F
authors.initials: F
authors.lastname: Calon
authors.forename: T
authors.initials: T
authors.lastname: Di Paolo
authors.forename: P J
authors.initials: PJ
authors.lastname: Bédard
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism
chemical_list: D011954:Receptors, Dopamine; D007980:Levodopa; D004298:Dopamine